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were satisﬁed with their health coverage (3.78 1.89).
Respondents in this study had low physical (PC) (47.23
± 9.69) and mental (MC) (47.11 ± 11.33) composite
scores on the SF-12 scale. There was a signiﬁcant corre-
lation between involvement in activities to improve health
and patient satisfaction scores. CONCLUSIONS: Con-
sumers were highly motivated to improve their health.
Health involvement could be used as a predictor of
humanistic outcomes in future studies.
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OBJECTIVE: To identify predictive factors of inpatient
drug costs in a 500-bed mother-child teaching hospi-
tal. METHODS: All hospitalisations in 2000/2001 and
2001/2002 were evaluated. Categorical variables in-
cluded were major category of diagnosis (MCD) (n =
25), severity index (n = 4), risk index (n = 4) and patient
care units (n = 41). Continuous variables included were
patient weight (kg), level of intensity of resources utilised
(LIRU) and total inpatient drug costs/patient-year. Out-
liers were excluded: inpatient drug costs/patient-year
greater than 5000 $CDN, LIRU > 50 and MCD with less
than 10 patients per ﬁscal year. MCD were analysed 
as serial dichomotical variables. Data were extracted
from the admission and the pharmacy software system.
RESULTS: Analysis were based on a cohort of 8479
patients in 2000/2001 and 7355 patients in 2001/2002.
Cost was divided by patient’s body weight and log-
transformed. A stepwise block multiple regression was
processed in two blocks: a ﬁrst block included LIRU,
severity index and risk index and a second block added
relevant MCD. Cumulative R2 were respectively 29.3 and
33.5 for both ﬁscal year. The standardised weight of the
variables included for both years were similar. Individual
R2 were 15.7 and 19.4 for LIRU, 4.7 and 3.3 for sever-
ity index, 0.1 and 0.2 for risk index and 8.9 and 10.6 for
a selection of relevant MCD. A third of total inpatient
drug costs/patient-year can be explained by level of inten-
sity of resources utilised, some major category of diag-
nosis, severity index and risk index. CONCLUSIONS:
There are limited information published on predictive
factors of inpatient drug costs/patient-year in hospitals.
Further analyses are required to build a useful and
stronger model for planning and benchmarking drugs
costs in hospitals.
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OBJECTIVE: Evaluate the impact of 3-tier pharmacy
beneﬁt structures on medication switching patterns.
METHODS: The study design was a “pre”-test/”post”-
test quasi-experimental design with comparison groups
using chronic disease sufferers from a health plan in the
Western US. Individuals with 2 prescriptions for a non
formulary medication (n = 1729) were classiﬁed by their
pharmacy beneﬁt group as: a) 2-tier moving to a 3-tier
structure, (“converting” group); b) 2-tier staying in a 2-
tier structure; and c) 3-tier staying in a 3-tier structure.
The latter two were “comparison” groups. Two time
periods were studies: the “pre” period before and the
“post” period, after a change in pharmacy beneﬁt struc-
ture. Cox regressions, adjusting for age, gender, chronic
disease scores and pharmacy plan structure, assessed dif-
ferences in the continuation rates of non formulary med-
ications across all groups. RESULTS: Over 60% switched
to formulary alternatives when faced with increased co-
payments, of which 43.3% switched to a brand alter-
native (p < 0.001). Less than 10% discontinued their
medication. Cumulative continuation rate was higher 
for the converting group: 30.1% (95% CI 27.6%–
34.1%) and similar for members in the two-tier compar-
ison group: 26% (95% CI 21.2%–32.6%). Three-tier
comparison group members were half as likely to con-
tinue their non formulary medications during the post
period: 17.1% (95% CI 14.3%–20.4%). CONCLU-
SIONS: Individuals confronted with increased co-
payments due to the implementation of a three-tier plan
often switched their medications to formulary alterna-
tives. While this ﬁnding supports the general purpose of
three-tier structures, of concern is the potential impact on
individuals who discontinued their medications due to
these changes.
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OBJECTIVE: Among OECD countries Korea has the
highest rate of out-of-pocket payments (OOP) in the
health care system. This has been pointed out and sug-
gested that it should be much lower. This study investi-
